Improved Risk-Adjusted Survival for Melanoma Brain Metastases in the Era of Checkpoint Blockade Immunotherapies: Results from a National Cohort

Overview of attention for article published in Cancer Immunology Research, September 2018

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#11 of 1,611)
High Attention Score compared to outputs of the same age (98th percentile)
High Attention Score compared to outputs of the same age and source (97th percentile)

So far, Altmetric has seen 41 news stories from 25 outlets.

FROM CANCER IMMUNOLOGY RESEARCH Since the Food and Drug Administration first approved checkpoint blockade immunotherapy (CBI…

An astounding 20% to 30% of people with cancer develop metastatic brain cancer (MBC)—cancer that has spread from another organ…

Here are what the editors at HealthDay consider to be the most important developments in Pharmacy for September 2018.

Here are what the editors at HealthDay consider to be the most important developments in Neurology for September 2018.

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity, including 37 additional news stories.